CU Â鶹¹ÙÍø researchers and the CU spinoff VitriVax Inc., are focused on finding a way to get vaccines to 7.8 billion people. The research team is able to do so with funding, licensing and startup support from Venture Partners at CU Â鶹¹ÙÍø, the university’s commercialization arm.